Medwellai (MWAI) Stock Price, News & Analysis

MedWellAi, Inc. (MWAI) is an AI-driven healthcare and wellness company whose business operations span e-commerce pharmaceutical distribution, telemedicine platforms, and health-focused real estate and software solutions. According to company disclosures, MedWellAi operates as a portfolio company that develops, acquires, and licenses technology and platforms with growth potential in healthcare and wellness. The company trades on the OTCQB market under the symbol MWAI.

MedWellAi reports that its business is organized into three primary operating entities: MedWell USA, LLC; MedWell Direct, LLC doing business as TeleMD.Ai; and MedWell Facilities, LLC. Together, these entities are intended to support an integrated healthcare ecosystem that combines AI-enhanced telehealth, wellness services, and pharmaceutical product distribution for both business and consumer clients.

MedWell USA, LLC – B2B Pharma Distribution and E‑Commerce

MedWell USA, LLC functions as a B2B e-commerce ordering portal and distribution channel for pharmaceutical and wellness products. Company materials state that this unit focuses on serving medical offices, wellness clinics, gyms, and online telemedicine companies. MedWell USA has disclosed a revenue share distribution agreement with a licensed pharmaceutical supplier and a master licensing agreement with an AI software developer to access an e-commerce ordering platform that includes tools for digital ordering, shipping, compliance automation, CRM management, and real-time operational analytics.

Through this structure, MedWell USA positions itself as a technology-enabled distributor to healthcare and wellness providers, emphasizing digital ordering and operational automation rather than traditional manual processes. The focus on B2B customers in healthcare, wellness, and fitness settings reflects the company’s stated emphasis on supporting clinics, gyms, and telemedicine operators with compliant pharmaceutical distribution.

TeleMD.Ai – B2B/B2C Telemedicine Platform

MedWell Direct, LLC dba TeleMD.Ai is described by the company as the developer and operator of a B2B/B2C telemedicine platform that connects consumers, corporations, and employees with licensed healthcare providers. MedWellAi has announced a software development agreement with BrighterMD (also known as Doctegrity) to build and launch TeleMD.Ai as a nationwide healthcare and wellness telemedicine platform, with a primary focus on the corporate healthcare benefits and wellness market.

The company states that TeleMD.Ai is designed to provide telehealth primary care that is affordable and accessible through desktop and mobile applications. The platform is planned to offer subscription-based access for both retail and corporate clients, with unlimited access to healthcare providers and certified telehealth therapists, nationwide 24/7 availability via smart devices or desktops, and no co-pays or cancellation fees as described in company communications.

According to MedWellAi, TeleMD.Ai targets two main market segments: business-to-consumer (B2C) and business-to-business (B2B). For individuals and families, the company describes simple-to-use telemedicine services with affordable monthly subscriptions and unlimited appointments. For employers, TeleMD.Ai is presented as a group benefit option that can be integrated into existing benefits packages via API integrations or EDI file transfers, with the stated goal of reducing insurance premiums while offering employees and their families primary care and mental health support with confidential appointments.

TeleMD.Ai Platform Components and AI Features

Company materials outline several key components of the TeleMD.Ai platform. These include primary care telemedicine, where users can connect with board-certified doctors by phone or video for diagnosis and prescriptions, with prescriptions sent to the pharmacy of the user’s choice. MedWellAi states that it intends to deploy custom AI agents to provide real-time personalized healthcare assessments, coaching, and support by analyzing data from wearable devices, smart scales, and patient-reported outcomes, and then generating tailored recommendations.

The platform is also described as offering telehealth therapy consultations, providing access to licensed therapists and counselors for mental and behavioral health support by phone or video. MedWellAi highlights behavioral and mental benefit coverage with 24/7 access to licensed counselors and therapists, and additional services such as financial and legal consultations, life coaching, medical advocacy, and nutritional counseling. The company indicates that AI agents are expected to help identify signs of depression or distress and connect individuals with human therapists when appropriate.

MedWellAi further describes exclusive lifestyle and wellness offerings under its brand, including programs related to weight loss management, energy and longevity, men’s health, women’s health, dermatology, IV therapy, hormone replacement, sexual health, and skincare. These areas are presented as part of a broader wellness management and discounted pharmaceutical products strategy tied into the TeleMD.Ai ecosystem.

Pharmacy Benefits, Biometric Tools, and Additional Services

According to company disclosures, TeleMD.Ai is connected to a large network of pharmacies and offers discounted pharmacy benefits. Members are described as having access to a list of commonly prescribed medications at no cost after a telemedicine consultation, with prescriptions available for pickup at participating pharmacies. Company materials also reference chronic condition medications with home delivery at no co-pay, a diabetes program at no added cost, discounts on over-the-counter medications, and savings on prescriptions and lab work at specified lab providers.

MedWellAi also describes a biometric tool called the LifeVitals app, which is presented as a mobile application that uses a smartphone’s camera to provide contactless vital sign readings. The company states that this app offers blood pressure and heart rate monitoring, real-time vitals and history, the ability to share results with healthcare providers, and trend tracking over time. The app is described as FDA registered with completed clinical trials and a stated accuracy level on key vital signs, according to the company’s news release.

Additional optional services mentioned by the company include TelePetCare solutions, which provide access to licensed veterinarians for pet emergencies, checkups, and prescriptions, as well as discounted services such as prescriptions, lab work, hearing aids, eye care and vision exams, dental coverage, gym and wellness memberships, and certain testing services. MedWellAi also notes that TeleMD.Ai offers bilingual services, with English and Spanish-speaking board-certified doctors and mental health therapists, which the company positions as a differentiating feature for employers with diverse workforces.

MedWell Facilities, LLC – Health and Wellness Real Estate and Software

MedWell Facilities, LLC is described as focusing on developing and managing real estate opportunities designed to attract health and wellness tenants, along with an AI-driven software platform. The company states that this software is intended to optimize operational models for weight loss, wellness, IV therapies, aesthetics, and traditional healthcare clinics through a licensing model. MedWellAi has disclosed that MedWell Facilities launched operations with the opening of a managed location in partnership with a fitness club owner and a wellness tenant, illustrating how the real estate and operational software components are combined.

Through this subsidiary, MedWellAi positions itself in the physical clinic and wellness facility space, focusing on attracting tenants and providing technology to streamline operations. The emphasis on AI-driven platforms for clinic optimization aligns with the broader corporate theme of applying automation and data-driven tools to healthcare and wellness delivery.

Corporate Rebranding and Strategic Focus

MedWellAi has publicly disclosed that it completed a corporate rebranding and transformation from Integrated Ventures, Inc. to MedWellAi, Inc., with a new trading symbol MWAI on the OTCQB market. The company describes itself as a rapidly growing AI-driven healthcare ecosystem integrating e-commerce enterprise SaaS, group purchasing and distribution, direct-to-consumer offerings, and corporate telehealth solutions. Management commentary characterizes MedWellAi’s strategy as targeting direct-to-consumer subscribers, clinics, gyms, and corporate clients, with a focus on compliant pharmaceutical distribution and AI-driven digital healthcare and wellness innovation.

According to company statements, MedWellAi seeks to use AI automation, data-driven decision-making, and scalable SaaS platforms to build healthcare infrastructure aimed at supporting longevity and patient well-being. The combination of B2B pharmaceutical distribution, telemedicine and wellness services, and health-focused real estate and software reflects the company’s multi-pronged approach to the healthcare and wellness sector.